The Germany generic drugs market is expected to grow at a CAGR of 6.25% from 2024 to 2032. Key factors driving this growth include rising healthcare costs, patent expirations of major branded drugs, supportive government policies, an increasing prevalence of chronic diseases, a growing focus on cost-effective treatment options, and an aging population https://www.imarcgroup.com/germany-generic-drugs-market